3/17/25 06:01 | 3/14/25 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | NY | DO | CEO | M.d | 44 | 7.20 | 0 | 6 | 2 | 306 | D | | | | | | | | | | | | | | |
3/6/25 16:10 | 3/4/25 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | NY | DO | CEO | M.d | 56 | 7.20 | 0 | 8 | 3 | 300 | D | | | | | | | | | | | | | | |
3/6/25 16:10 | 3/4/25 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | NY | DO | CEO | S.d | -118 | 15.05 | 0 | -8 | -3 | 300 | D | | | | | | | | | | | | | | |
2/12/25 17:15 | 2/10/25 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | S | -206 | 15.50 | 0 | -13 | -4 | 300 | D | | | | | | | | | | | | | | |
2/8/23 16:49 | 2/6/23 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | M.d | 38 | 6.38 | 0 | 6 | 51 | 18 | D | | | | | | | | | | | | | | |
2/8/23 16:49 | 2/6/23 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | S.d | -165 | 27.64 | 0 | -6 | -25 | 18 | D | | | | | | | | | | | | | | |
11/10/22 16:54 | 11/8/22 | CTIC | Cti Biopharma Corp | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | WA | D | | M.d | 87 | 0.9505 | 0 | 92 | | 0 | D | | | | | | | | | | | | | | |
11/10/22 16:54 | 11/8/22 | CTIC | Cti Biopharma Corp | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | WA | D | | S.d | -511 | 5.58 | 0 | -92 | -100 | 0 | D | | | | | | | | | | | | | | |
10/7/22 16:05 | 10/6/22 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | M.d | 142 | 8.77 | 0 | 16 | 999% | 18 | D | | | | | | | | | | | | | | |
10/7/22 16:05 | 10/6/22 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | S.d | -411 | 25.29 | 0 | -16 | -48 | 18 | D | | | | | | | | | | | | | | |
10/4/22 17:49 | 9/30/22 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | M.dm | 296 | 8.77 | 0 | 34 | | 18 | D | | | | | | | | | | | | | | |
10/4/22 17:49 | 9/30/22 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | S.dm | -845 | 25.02 | 0 | -34 | -66 | 18 | D | | | | | | | | | | | | | | |
7/27/22 18:42 | 7/25/22 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | M.d | 202 | 6.38 | 0 | 32 | | 18 | D | | | | | | | | | | | | | | |
7/27/22 18:42 | 7/25/22 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Metzger Michael A | MA | DO | CEO | S.d | -665 | 21.06 | 0 | -32 | -64 | 18 | D | | | | | | | | | | | | | | |